The Science of Circadian Rhythms: How Peripheral Clocks in Organs Control Metabolism
7 sources · 6d ago
Scientists Identify Protein That Mimics Calorie Restriction's Anti-Aging Effects, Opening Door to New Longevity Drugs
7 sources · 11d ago
Ozempic Works by Unexpectedly Activating Brain's Hunger Neurons to Sustain Fat Loss
4 sources · 16d ago
More in Medicine
FDA Approves First Gene Therapy for Congenital Deafness, Restoring Hearing in Children
6 sources · 22d ago
Blood Biomarker Predicts Chemotherapy Benefit in Breast Cancer, Sparing Thousands of Women
7 sources · 34d ago
Next-Generation KRAS Inhibitor Divarasib Shows Superiority Over Approved Drugs in Head-to-Head Lung Cancer Trial
8 sources · 51d ago
Blindspot
Important stories the mainstream barely covered
High-impact news with only 1–3 outlets covering it. These stories matter — they just didn't make the radar.
World-First Trial Finds Statins Safely Cut Heart Attack Risk in Healthy Adults Over 70
A landmark clinical trial has demonstrated that daily statin use significantly reduces the risk of heart attacks and strokes in healthy adults over 70 without increasing disability or dementia risks. The findings resolve a long-standing medical debate about whether the cholesterol-lowering drugs benefit older populations with no prior history of cardiovascular disease.
FDA-Approved Cancer Drug Epcoritamab Misses Overall Survival Endpoint in Confirmatory Phase 3 Trial
The bispecific antibody epcoritamab failed to significantly extend overall survival compared to standard chemotherapy in a confirmatory trial for relapsed diffuse large B-cell lymphoma.






